Search results
Ray Romano Says Starring on “Everbody Loves Raymond” with Peter Boyle Was 'Surreal': 'He Made Me...
People via Yahoo News· 8 hours agoRomano reflects on the late actor who died in 2006 from multiple myeloma and heart disease Jeff...
New Agent Shows Early Promise in Triple-Class Refractory MM
Medscape· 2 days agoWith linvoseltamab and other bispecific antibodies inducing deep and durable responses, there might...
...Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients...
NBC 10 - FOX 14 Monroe· 2 days agoThe poster will be presented at the American Society for Apheresis (ASFA) 2024 Annual Meeting, taking place April 17-19, 2024, in Las Vegas, Nevada.
J&J sees mixed performance from new multiple myeloma drugs
BioPharma Dive via Yahoo Finance· 3 days agoTecvayli sales, which J&J broke out for the first time, surpassed Wall Street forecasts and offset...
Xpovio: Mild to serious side effects and how to manage them
Medical News Today· 17 hours agoXpovio, which is used to treat multiple myeloma, can cause side effects. Learn about its more...
Adaptive Biotechnologies Shares Surge as FDA Panel Recommends MRD as Endpoint in Multiple Myeloma
GenomeWeb News· 4 days agoSeattle-based Adaptive offers the FDA-cleared ClonoSeq assay for MRD testing in hematologic cancers, including multiple myeloma. The vote from FDA's Center ...
2seventy bio (TSVT) Rises More Than 50% in 3 Months: Here's Why
Zacks via Yahoo Finance· 2 days agoThe FDA's recent nod to 2seventy bio's (TSVT) Abecma in earlier lines of treatment for...
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and...
Zacks via Yahoo Finance· 7 days agoThe therapy is now approved for the treatment of adult patients with relapsed or refractory multiple...
International Myeloma Foundation Celebrates ODAC Meeting Outcome on Minimal Residual Disease (MRD)...
Morningstar· 6 days agoBrian G.M. Durie and the presentations from members of the collaborative research group, the i2TEAMM, the Oncologic Drug Advisory Committee (ODAC) unanimously voted in favor (12-0) of using ...
‘It’s taken a Tudor lifetime to get it made’: How Shardlake finally got the TV treatment
Daily Telegraph· 6 days agoThe bond with Shardlake goes deep. Now 74, Sansom hasn’t visited the filming (in 2012 he was...